A federal appellate court decision could send foie gras off the menu—again.
FDA should encourage states to be the primary regulators of stem cell procedures.
New study shows regulators have overlooked insurers in tackling the opioid epidemic.
Expert argues that federal law gives regulator authority to restrict unauthorized drug uses.
New study suggests that cities can encourage local food production and consumption through smarter regulations.
Lawyer argues that United States should ramp up regulation of dietary supplements.
Scholar argues U.S.-China trade agreements fill regulatory gaps left by both countries.
Amid growing concerns about “superbugs,” regulators seek comment on use of antimicrobials in animal feed.
FDA is years behind in its statutory mandate to put graphic warnings on cigarette labels.
Scholar argues that regulators will have difficulty applying cost-benefit analysis to mandatory GMO labeling.
Regulator solicits input on a new rule defining when foods could be considered “healthy.”
As drug prices spike, the presidential candidates endorse proposals for getting costs down.